{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:23:36Z","timestamp":1790497416948,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T00:00:00Z","timestamp":1401667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-391","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T11:16:44Z","timestamp":1401707804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Aspirin intake and breast cancer survival \u2013 a nation-wide study using prospectively recorded data in Sweden"],"prefix":"10.1186","volume":"14","author":[{"given":"Michelle D","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Pawitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese M-L","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Ekstr\u00f6m","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,2]]},"reference":[{"issue":"1","key":"4605_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cncr.11859","volume":"100","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN: Is breast cancer survival improving?. Cancer. 2004, 100 (1): 44-52. 10.1002\/cncr.11859.","journal-title":"Cancer"},{"issue":"27","key":"4605_CR2","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351 (27): 2817-2826. 10.1056\/NEJMoa041588.","journal-title":"N Engl J Med"},{"key":"4605_CR3","doi-asserted-by":"crossref","unstructured":"Breast cancer in developing countries. Lancet. 2009, 374 (9701): 1567-10.1016\/S0140-6736(09)61930-9. doi:10.1016\/S0140-6736(09)61930-9","DOI":"10.1016\/S0140-6736(09)61930-9"},{"issue":"2","key":"4605_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/bcr3336","volume":"14","author":"MD Holmes","year":"2012","unstructured":"Holmes MD, Chen WY: Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res. 2012, 14 (2): 216-10.1186\/bcr3336.","journal-title":"Breast Cancer Res"},{"key":"4605_CR5","volume-title":"Background Facts, Labour and Education Statistics 2009:1, Integrated database for labour market research","author":"Statistics Sweden","year":"2009","unstructured":"Statistics Sweden: Background Facts, Labour and Education Statistics 2009:1, Integrated database for labour market research. 2009, Statistics Sweden"},{"issue":"7","key":"4605_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M: The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007, 16 (7): 726-735. 10.1002\/pds.1294.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"4605_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199607253350404","volume":"335","author":"LE Hansson","year":"1996","unstructured":"Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF, Adami HO: The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996, 335 (4): 242-249. 10.1056\/NEJM199607253350404.","journal-title":"N Engl J Med"},{"issue":"1","key":"4605_CR8","first-page":"1007","volume":"1","author":"RS Kim","year":"2013","unstructured":"Kim RS: Lesser known facts about nested case\u2013control designs. J Transl Med Epidemiol. 2013, 1 (1): 1007-","journal-title":"J Transl Med Epidemiol"},{"issue":"6","key":"4605_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","volume":"18","author":"ML Kwan","year":"2007","unstructured":"Kwan ML, Habel LA, Slattery ML, Caan B: NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007, 18 (6): 613-620. 10.1007\/s10552-007-9003-y.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"4605_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","volume":"101","author":"CK Blair","year":"2007","unstructured":"Blair CK, Sweeney C, Anderson KE, Folsom AR: NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat. 2007, 101 (2): 191-197. 10.1007\/s10549-006-9277-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"4605_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE: Aspirin intake and survival after breast cancer. J Clin Oncol. 2010, 28 (9): 1467-1472. 10.1200\/JCO.2009.22.7918. doi:10.1200\/JCO.2009.22.7918. Epub 2010 Feb 16. PMID: 20159825","journal-title":"J Clin Oncol"},{"issue":"9826","key":"4605_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z: Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012, 379 (9826): 1591-1601. 10.1016\/S0140-6736(12)60209-8.","journal-title":"Lancet"},{"issue":"5","key":"4605_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM: Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012, 13 (5): 518-527. 10.1016\/S1470-2045(12)70112-2. doi:10.1016\/S1470-2045(12)70112-2. Epub 2012 Mar 21. Review. PMID: 22440112.","journal-title":"Lancet Oncol"},{"key":"4605_CR14","unstructured":"Pharmaceuticals - Statistics for 2009. http:\/\/www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/18278\/2011-3-30.pdf ,"},{"issue":"1","key":"4605_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1158\/1055-9965.EPI-11-1012","volume":"21","author":"Y Li","year":"2012","unstructured":"Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL: Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2012, 21 (1): 239-242. 10.1158\/1055-9965.EPI-11-1012.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"4605_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1055-9965.EPI-11-1089","volume":"21","author":"L Cheng","year":"2012","unstructured":"Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH: Hazard of recurrence among women after primary breast cancer treatment\u2013a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev. 2012, 21 (5): 800-809. 10.1158\/1055-9965.EPI-11-1089.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-391\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T10:12:54Z","timestamp":1498126374000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-391","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,2]]},"article-number":"391"}}